about
New Findings on Breast Cancer Stem Cells: A ReviewDeoxyribonucleic acid damage-associated biomarkers of ionising radiation: current status and future relevance for radiology and radiotherapyHemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy.Phase I study of bortezomib in combination with irinotecan in patients with relapsed/refractory high-risk neuroblastoma.Efficacy of radiosensitizing doped titania nanoparticles under hypoxia and preparation of an embolic microparticle.Design of an intelligent sub-50 nm nuclear-targeting nanotheranostic system for imaging guided intranuclear radiosensitization.Reducing X-Ray Induced Oxidative Damages in Fibroblasts with Graphene Oxide.Hypoxia and radiation therapy: past history, ongoing research, and future promise.Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle.Alkoxyamines: a new family of pro-drugs against cancer. Concept for theranostics.F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapyUltrasmall glutathione-protected gold nanoclusters as next generation radiotherapy sensitizers with high tumor uptake and high renal clearance.Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy.Ionizing radiation-induced foci persistence screen to discover enhancers of accelerated senescence.Analysis of Radiomodulatory Effect of Low-Level Laser Irradiation by Clonogenic Survival AssayModeling human choroidal melanoma xenograft growth in immunocompromised rodents to assess treatment efficacy.Synthesis of novel galactose functionalized gold nanoparticles and its radiosensitizing mechanism.Using high harmonic radiation to reveal the ultrafast dynamics of radiosensitiser molecules.Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo.Enhancement of the radiation response of EMT-6 tumours by a copper octabromotetracarboranylphenylporphyrin.pH-responsive hydrogels containing PMMA nanoparticles: an analysis of controlled release of a chemotherapeutic conjugate and transport properties.Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancerThe contribution of growth hormone to mammary neoplasiaThe synergistic radiosensitizing effect of tirapazamine-conjugated gold nanoparticles on human hepatoma HepG2 cells under X-ray irradiation.The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells.The importance of radiation chemistry to radiation and free radical biology (The 2008 Silvanus Thompson Memorial Lecture).Synthesis and Biological Evaluation of Iodoglucoazomycin (I-GAZ), an Azomycin-Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic TumorsX-Ray Induced Photodynamic Therapy: A Combination of Radiotherapy and Photodynamic TherapyRadiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers.Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches.Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia.EPR oxygen images predict tumor control by a 50% tumor control radiation dose.Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical SettingsKelussia odoratissima potentiates cytotoxic effects of radiation in HeLa cancer cell line.Transport processes of radiopharmaceuticals and -modulators.Continuing pursuit for ideal systemic anticancer radiotherapeutics.Is Nitric Oxide (NO) the Last Word in Radiosensitization? A Review.Current and emerging strategies to increase the efficacy of ionizing radiation in the treatment of cancer.The potential roles of bacteria to improve radiation treatment outcome.Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia.
P2860
Q26771894-2BB72D46-2A8E-4393-8140-1789499CA4F1Q26866394-2415892F-BFF2-4175-B62D-269D373473D4Q30524018-56BF0F94-DBF1-4160-80CE-84C7ECCC4B13Q33441292-9F9FD09B-1E47-4D0F-B1CE-01FDFE020C59Q33719209-FAD3BBF3-09A4-4765-B2C5-5A5673A0D164Q33838165-3A682A27-4A6E-4A64-8156-8376CFA0BAEEQ34724034-E0CB063A-3146-4545-9772-49919301EE70Q34986265-73DFD293-2EE1-44F4-8321-4358B0E673D3Q35016037-79951DA5-8662-4C9D-8F94-5B385E368731Q35066682-B2F1BD9C-04C2-4B9C-B3CC-9C030E47E98CQ35116993-AFF0F2A5-BC6A-468F-A349-C6E30FBEFC0AQ35133948-17326009-268D-4C77-B55B-B289154154ABQ35143081-350B9FE8-C3C0-4DD6-A7A8-2B9FC157936AQ35670160-59B53DA9-65D6-4088-A172-E07958FA64D4Q35762559-5254E153-8E7F-47E2-92A5-A1A435CEBEB3Q35975881-5ABE4A03-7A1A-495A-BDB1-5B74502A05F2Q36144086-E38FAC18-0719-4714-9C3F-8032A0F38A74Q36158999-656A9BB4-78B4-4992-910D-C7B6CB45555FQ36224524-E2B6A696-8CC8-48E2-BAE0-65E0A258FF28Q36364391-8F0A7E2F-E7D6-47BC-9A5A-36B68D27DC80Q36870775-BD0308DD-CF37-4D35-950F-02351C3AF86AQ37002085-F1D197FB-EA38-443C-AFB0-5BCEB5F0186BQ37078157-3412F30A-A533-488C-9CCF-4D09514F09C8Q37146136-5FC5500B-70DF-4150-BFDE-8C3D458611EBQ37276709-B2979DA1-36BC-4687-968D-1D82D33AA9DCQ37377149-06F74D5D-497D-4572-9A39-DA1298B97986Q37394242-86C292AA-1397-4025-98B4-4D00E3B46082Q37427803-FE870708-6F6B-46C0-B019-5CDF1EE33958Q37481367-56A9251D-75A8-4655-8E94-123660B1C0E7Q37489947-C72B7350-7F6C-45F5-AFE3-36745B0B6D7CQ37491250-CD29B3D2-C4BF-4DA5-9B1A-226BA96EDE5DQ37553842-9B505262-B872-4BB1-8048-340670FD1E71Q37604088-AB9B8D78-29EC-490E-A8C1-6497AE88FB5EQ37707836-03952DA6-B57E-4F15-B910-6196E31342E4Q37885468-965D1DAA-8480-4734-A176-1B63D60CB5E9Q37946750-CB42C73E-5466-4650-8384-8E9871D4BAC0Q38002028-9A5A7B1C-5742-4792-8999-A3A6EBDFC0E2Q38174090-C9987336-E71A-4782-9158-FC614B847781Q38670007-EAEDD7B3-A011-45D5-BEAA-504512423939Q38725902-443C6529-77D6-4675-8046-7A667335730C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemical radiosensitizers for use in radiotherapy.
@ast
Chemical radiosensitizers for use in radiotherapy.
@en
type
label
Chemical radiosensitizers for use in radiotherapy.
@ast
Chemical radiosensitizers for use in radiotherapy.
@en
prefLabel
Chemical radiosensitizers for use in radiotherapy.
@ast
Chemical radiosensitizers for use in radiotherapy.
@en
P1433
P1476
Chemical radiosensitizers for use in radiotherapy.
@en
P2093
P304
P356
10.1016/J.CLON.2007.03.010
P577
2007-05-02T00:00:00Z